We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: erippetoe who wrote (53661)1/13/2020 6:16:54 PM
From: zevenhuizen4 Recommendations

Recommended By

  Respond to of 59218
Probably is and , because of that, dropped the price right at the open. All those people on WS are in bed with each other, no question.Remember now , they are all out to try to separate you from your money.It's all part of the game.

To: erippetoe who wrote (53661)1/13/2020 7:45:09 PM
From: erickerickson2 Recommendations

Recommended By

  Read Replies (1) | Respond to of 59218
As you may remember, I'm not much for conspiracy theories, I think there's too many disparate forces at work for a concerted effort and they'd all have to work together to be effective, and my gut feel is any one of them would cheerfully sell out the rest.

But this kind of thing is enough to make me change my mind. What I love about this is there's absolutely no explanation of _why_ the margin requirements changed. IIRC this happened a year or two ago as well. And I have to wonder whether they raised the margin requirements for IMMU in general for all their clients or whether you're "special".

You say you got one "last week or week before". I'd guess the week before when the price started dropping. I suppose on the bright side they can't raise it much more.

Hmmm, and options are expiring Friday, another group who could have made some money if they were prepared for the drop.

I decided to try to see what the margin requirements were for my brokerage (Citi for reasons I won't go in to now) and couldn't find anything easily so I don't have a clue whether it's local to ETrade or not.

But on the Citi site there's a "Markit Research Team Consensus Report". And yes, it's "Markit". The 7 ratings services have 0-buy 2-hold and 5-sell. But then there's this gem:

"ResearchTeam's rating was correct 42.4% of the time, and incorrect 51.8% of the time", and "Coverage was dropped 5.8% of the time, due to less than 7 ratings"

So even if I give the "Research Team" the maximum benefit that whenever there were "less than 7" ratings services the call would have been correct, the "Research Team" is worse than flipping a coin!

Finally, I do wonder how much of a floor there is at the $17.50 range. Given that the recent offering was oversubscribed, how many institutions are waiting to snap up shares in that range? I have no clue of course, but it's fun to speculate.